“Ay juemadre,” Liliana Lesmes whispered. For the bacteriological expert and measles and rubella lead at Bogotá’s Health Secretariat, the words were a visceral reaction to a clinical reality: the first confirmed case of measles in the Colombian capital in over a decade. Aside from a contained outbreak in the Caribbean region in 2019, the city had long enjoyed a reprieve from the virus.
That single case was the spark for a larger alarm. By early March, the National Institute of Health (INS) had confirmed four cases—three in Bogotá and one in Bucaramanga. All were identified as imported cases from Mexico, where the virus is currently circulating with significant force. While these initial cases were contained, they have exposed a precarious vulnerability in Colombia’s public health shield just as the country prepares for the massive influx of international visitors for the World Cup.
For health authorities, the timing is critical. Bogotá, a metropolis of eight million people and home to the most transit-heavy airport in Latin America, serves as the primary gateway for the country. The intersection of high international mobility, active transmission in neighboring North American countries, and uneven vaccine coverage has created what experts describe as a volatile environment for the riesgo de sarampión en Bogotá.
The North American Epicenter and the ‘Perfect Storm’
The threat is not theoretical; it is numerical. Since January 1, 2025, Mexico has confirmed 15,479 cases. The surge extends northward, with the United States reporting 3,981 cases and Canada recording 5,751 as of March 28. Canada’s situation is particularly stark, having lost its certification as a measles-free country after more than a year of endemic transmission.
From a clinical perspective, measles is far from a benign childhood illness. As a physician, I have seen how the virus targets the most vulnerable. According to pediatric infectious disease specialist Juan Pablo Londoño, approximately one in ten children under the age of four will develop severe complications. These range from otitis and encephalitis to pneumonia, which remains the leading cause of measles-related death.
Beyond the acute phase, the virus can leave a lasting scar on the immune system. Sub-secretary of Public Health Julián Fernández-Niño notes that measles can induce a permanent immune deficit in 20% to 30% of cases, leaving patients more susceptible to other infections long after the rash has faded.
The primary driver of this risk is the virus’s staggering transmissibility. While the influenza virus typically infects an average of two people and the most contagious variants of Covid-19 can infect up to seven, measles can spread to as many as 18 unvaccinated individuals. This exponential potential makes the prevención del sarampión en Bogotá a matter of urgent mathematical necessity.
The Gap in the Shield: ‘Pockets of Susceptibles’
To achieve herd immunity and stop the spread of measles, a population requires a vaccination coverage rate of at least 95%. Colombia is currently falling short, hovering around 90% for the pediatric population, with some regional disparities dropping as low as 80%.
Bogotá presents a complex internal map of immunity. While the city achieves a 95.6% coverage rate for children under five, that number drops to 89% for infants under 18 months. Even more concerning is the adult population; due to a lack of reliable historical records, the actual vaccination status of millions of adults remains an unknown variable.
Epidemiologist Zulma Cucunubá of Universidad Javeriana describes these gaps as “pockets of susceptibles”—concentrations of people who are either unvaccinated or have incomplete schedules. These gaps have widened since the pandemic, driven by disrupted healthcare access and falling immunization rates. In a simulation led by Cucunubá, the impact of these gaps is clear:
- With 95% coverage: Three imported cases would result in limited, easily controllable contagions.
- With 90% coverage: Those same three cases could rapidly escalate into hundreds of infections.
- With 30 imported cases: The city could see at least 1,000 cases within a few months, spreading from the initial group to the broader population.
A Strategy of Containment and Surveillance
To prevent a full-scale epidemic, the Mayor’s Office of Bogotá has deployed an integrated strategy focusing on early detection and rapid response. The process begins with the SIVIGILA surveillance system, which requires any suspected case—defined by fever and a maculopapular rash—to be reported within 24 hours.
Once a case is flagged, the city initiates a rigorous epidemiological “fence.” Health teams conduct house-to-house visits across five to nine city blocks surrounding the patient for at least a month, reviewing vaccination cards and immunizing anyone found to be unprotected. This precision tracking similarly extends to flight manifests, schools, and mass events to cut the chain of transmission before it can anchor locally.
The city is also employing geospatial analysis, overlaying vaccination data with poverty indicators and service access maps. This allows the Health Secretariat to concentrate vaccination campaigns in the neighborhoods most likely to harbor those “pockets of susceptibles.”
The Supply Chain Tension
Despite the robust surveillance framework, the strategy faces a significant hurdle: vaccine availability. While the city has sufficient stocks of the triple viral vaccine for children (approximately 100,000 doses), the supply for adults is precarious.
District Health Secretary Gerson Bermont has highlighted a disconnect with the national government. In February, Bogotá requested 50,000 bivalent vaccines for adults; the national government initially delivered only 5,000, which were exhausted in a single week. A subsequent request resulted in 20,000 doses. Bermont warns that while the city has not completely run out, the current delivery pattern is insufficient for a real emergency response.
| Group/Metric | Coverage/Amount | Status |
|---|---|---|
| Children < 5 years | 95.6% | Target Met |
| Children < 18 months | 89% | Below Target |
| Triple Viral (Children) | 100,000 doses | Sufficient |
| Bivalent (Adults) | Variable | Critical Shortage |
As the World Cup approaches, the goal is no longer to stop imported cases from entering—which Bermont says is nearly impossible—but to ensure those cases do not trigger local transmission. The most effective tool remains a complete vaccination schedule, especially for those planning to travel.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a healthcare provider or your local health authority to verify your vaccination status and receive medical care.
The next critical checkpoint will be the upcoming national health report from the Ministry of Health, which is expected to clarify the vaccine projection and distribution strategy for the remainder of the year. Until then, health officials urge anyone with doubts about their immunization history to seek vaccination immediately.
Do you have questions about your vaccination schedule or the risks associated with international travel? Share your thoughts in the comments or share this guide with someone traveling for the World Cup.
